{
    "medicine_id": "55532b00f6cbe9452bb6a5b95985de9a6a412e4a",
    "platform_id": "DB04912",
    "metadata": {
        "name": "Orbactiv 400 mg 1 Injection powder lyophilized for solution",
        "composition": "400 mg 1 Stannsoporfin",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in liver disease metabolic disease and pediatric indications",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Stannsoporfin is a chemical compound being investigated for use as a medicament in the treatment of infant jaundice Stannsoporfin is also known to inhibit heme metabolism in mammals to control the rate of tryptophan metabolism in mammals and to increase the rate at which heme is excreted by mammals",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}